SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-023863 from Ocean Biomedical, Inc. (OCEA, OCEAW) (CIK 0001869974) (OCEA)

Ocean Biomedical, Inc. (OCEA, OCEAW) (CIK 0001869974)
Date: July 6, 2023 · CIK: 0001869974 · Accession: 0001493152-23-023863

AI Filing Summary & Sentiment

File numbers found in text: 333-272859

Date
July 6, 2023
Author
Chief
Form
CORRESP
Company
Ocean Biomedical, Inc. (OCEA, OCEAW) (CIK 0001869974)

Letter

Claverick St., Room 325

Providence, Rhode Island 02903

July 6, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Attn: Lauren Hamill

Re: Ocean Biomedical, Inc.

Registration Statement on Form S-1

File No. 333-272859

Ladies and Gentleman:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-1 be accelerated so that the same will become effective at 4:30 p.m. Eastern Time on July 7, 2023, or as soon thereafter as practicable.

Very
truly yours,
OCEAN
BIOMEDICAL, INC.

Show Raw Text
CORRESP
1
filename1.htm

55
Claverick St., Room 325

Providence,
Rhode Island 02903

July
6, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

Attn:
Lauren Hamill

    Re:
    Ocean
                                            Biomedical, Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-272859

Ladies
and Gentleman:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effectiveness of the above-captioned
Registration Statement on Form S-1 be accelerated so that the same will become effective at 4:30 p.m. Eastern Time on July 7, 2023, or
as soon thereafter as practicable.

Very
truly yours,

OCEAN
BIOMEDICAL, INC.

    By:

    /s/
    Elizabeth Ng

    Name:

    Elizabeth
    Ng

    Title:

    Chief
    Executive Officer

    cc:
    Kate
    L. Bechen, Esq.

    Hallie
D. Heath, Esq.